MedGenome
A deep look at MedGenome's finances, team, and market position in the AI Healthcare space.
Awaira Score
Out of 100
HQ
India
Founded
2013
Raised
$264M
Stage
Series E
Team
200-500
About MedGenome
MedGenome is a genomics and precision medicine company that combines next-generation sequencing with AI-powered data analysis to deliver clinical genomic testing for rare diseases, hereditary cancers, and pharmacogenomics. The company operates a NABL-accredited genomics laboratory and a bioinformatics platform that interprets variant data against proprietary South Asian population…
Key Facts
- MedGenome has raised a total of $264M in disclosed funding across 6 funding rounds.
- MedGenome was founded in 2013 by Sam Santhosh and is headquartered in India.
- MedGenome employs approximately 200-500 people.
- MedGenome operates in the AI Healthcare category and is currently at the Series E stage.
- MedGenome has an Awaira Score of 63/100, ranking it among the tracked AI companies on Awaira.
- MedGenome's most recent funding round was a Series E of $84.48M closed in February 2020.
Source: Awaira · Updated Mar 24, 2026
Valuation
N/A
Post-money
Total Raised
$264M
All rounds
Awaira Score
63/100
Founded
2013
200-500 employees
Strengths & Risks
Strengths
Strong Awaira Score of 63/100
Large team of 200-500+ employees
Established market presence (founded 2013)
Considerations
Valuation not publicly disclosed
Analysis based on publicly available data. Not investment advice.
Funding Velocity
6
Total Rounds
$44M
Avg Round Size
6.8yr
Funding Span
MedGenome raised 6 rounds over 6.8 years, averaging $44M per round — a pace of roughly one round every 14 months.
Awaira estimate based on public data. Not financial advice.
How does MedGenome stack up against competitors?
Competitor Comparison
| Metric | ★MedGenome | Butterfly Network | Tempus | Alan |
|---|---|---|---|---|
| Awaira Score | 63/100 | 85/100 | 84/100 | 83/100 |
| Total Raised | $264M | $370M | $1.05B | $750M |
| Valuation | N/A | $957M | $8.1B | $5.83B |
| Stage | Series E | Public | Public | Series D |
| Founded | 2013 | 2011 | 2015 | 2016 |
| Employees | 200-500 | 500-1000 | 2500 | 500-1000 |
| Country | 🇮🇳 | 🇺🇸 | 🇺🇸 | 🇫🇷 |
Funding Rounds
Inactive$84.48M
Feb 2020
$73.92M
Oct 2018
$55.44M
Jun 2017
$31.68M
Feb 2016
$13.2M
Oct 2014
$5.28M
Jun 2013
MedGenome Latest News
Founded Same Year (2013)
Similar by Funding Stage (Series E)
More from India
🇮🇳 View all AI companies in India →Alternatives
View all alternatives to MedGenome →If you're looking at MedGenome, also check out
View all AI Healthcare →People Also Viewed
Frequently Asked Questions
What is MedGenome's valuation?▾
Who invested in MedGenome?▾
When did MedGenome last raise funding?▾
How many employees does MedGenome have?▾
What does MedGenome do?▾
Who founded MedGenome?▾
Is MedGenome profitable?▾
Where is MedGenome headquartered?▾
Compare MedGenome
See how MedGenome stacks up against competitors in valuation, funding, team size, and Awaira Score.